• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

Press Release:

Global Non-Invasive Prenatal Testing Market to Grow at 12% During 2020-2025, Impelled by Increasing Prevalence of Fetal Chromosomal Abnormalities

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Non-Invasive Prenatal Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

The global non-invasive prenatal testing market exhibited strong growth during 2015-2020. Non-invasive prenatal testing (NIPT) is a form of prenatal screening conducted on a pregnant woman’s blood sample to detect the presence of fetal abnormalities. The test is primarily used to diagnose genetic disorders such as Down syndrome (or trisomy 21), Edwards syndrome (or trisomy 18),  Patau syndrome (or trisomy 13) and Turner syndrome, by analyzing DNA fragments in the mother’s blood. The procedure eliminates the need for various precarious and invasive procedures, such as chorionic villus sampling (CVS) and can be performed after nine weeks of pregnancy.

The growing prevalence of genetic disorders of the fetus is one of the key factors driving the market growth. Furthermore, technological advancements in the field of life sciences and healthcare industry is also providing a boost to the market. For instance, the development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have created immense possibilities to combat the chances of any serious disease at the primitive stage itself. Additionally, the increasing acceptance rate for prenatal testing, along with rising health consciousness and awareness regarding the benefits and significance of such testing among the masses, is also driving the market growth. Healthcare providers, as well as expecting parents, are adopting alternatives to diagnose other genetic disorders, including spina bifida, cleft palate, and sickle cell anemia, and treat them in the early stages of fetal development. Moreover, the shifting trend toward childbearing at high maternal age (35 years or older) is also positively impacting the market growth. Advancing maternal age can lead to numerous health complications, such as high blood pressure, reduced fertility, risk of miscarriage and increased risk of chromosomal anomalies in the fetus. Looking forward, IMARC Group expects the global non-invasive prenatal testing market to grow at a CAGR of 10.70% during 2021-2026.

Breakup by Product Type:

  • Consumables
  • Instruments
     

Breakup by Test Type:

  • Materni 21
  • Harmony
  • Panaroma
  • Verifi
  • NIFTY
  • Others
     

Breakup by Technology:

  • NGS
  • WGS
  • Others
     

Breakup by Test Type:

  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-Free DNA in Maternal Plasma Tests
  • Fetal Cells in Maternal Blood Tests
  • Others
     

Breakup by Application:

  • Trisomy
  • Microdeletions Syndrome
  • Others
     

Breakup by End-User:

  • Hospitals
  • Diagnostic Laboratories
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa


Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the top non invasive prenatal testing companies key players being Agilent Technologies Inc., Berry Genetics Inc., BGI Genomics Co. Ltd., Eurofins LifeCodexx GmbH, F. Hoffmann-La Roche AG, GE Healthcare, Igenomix, Illumina Inc., Laboratory Corporation, Natera Inc., Perkinelmer Inc., Thermo Fisher Scientific Inc., Yourgene Health, etc.

Key Questions Answered in This Report:

The global non-invasive prenatal testing market size was valued at US$ 2.13 Billion in 2020.

The sudden outbreak of the COVID-19 pandemic, in early 2020, has hampered the market growth due to the high risk of coronavirus contraction upon hospital visits for numerous medical procedures involved in the prenatal testing.

According to the estimates by IMARC Group, the global non-invasive prenatal testing market is expected to witness a CAGR of 10.70% from 2021 to 2026.

The high prevalence of genetic disorders in the fetus, along with the rising health awareness towards early disease detection at a primitive stage, is primarily driving the demand for non-invasive prenatal testing.

The development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have led to emergence of advanced testing solutions, thereby representing one of the key trends in the non-invasive prenatal testing market.

On the basis of the test type, the market has been bifurcated into ultrasound detection, biochemical screening tests, cell-free DNA in maternal plasma tests, fetal cells in maternal blood tests, and others. In this segment, ultrasound detection dominates the global market.

On the basis of the test type, the market has been bifurcated into ultrasound detection, biochemical screening tests, cell-free DNA in maternal plasma tests, fetal cells in maternal blood tests, and others. In this segment, ultrasound detection dominates the global market.

On the basis of the application, the market has been bifurcated into trisomy, microdeletions syndrome, and others, where trisomy holds the largest market share.

Based on the end-user, the market has been segmented into hospitals, diagnostic laboratories, and others, where diagnostic laboratories dominate the global market.

Region-wise, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.  Based on region, North America currently accounts for the largest market share.

1    Preface
2    Scope and Methodology 
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Non-Invasive Prenatal Testing Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product Type 
    6.1    Consumables
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Instruments
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Test Type
    7.1    Materni 21
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Harmony
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Panaroma
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Verifi
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    NIFTY
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8    Market Breakup by Technology
    8.1    NGS
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    WGS
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Method
    9.1    Ultrasound Detection
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Biochemical Screening Tests
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Cell-Free DNA in Maternal Plasma Tests
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Fetal Cells in Maternal Blood Tests
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5    Other Tests
        9.5.1 Market Trends
        9.5.2 Market Forecast
10    Market Breakup by Application
    10.1    Trisomy
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Microdeletion Syndrome
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    Others
        10.3.1 Market Trends
        10.3.2 Market Forecast
11    Market Breakup by End-User
    11.1    Hospitals
        11.1.1 Market Trends
        11.1.2 Market Forecast
    11.2    Diagnostic Laboratories
        11.2.1 Market Trends
        11.2.2 Market Forecast
    11.3    Others
        11.3.1 Market Trends
        11.3.2 Market Forecast
12    Market Breakup by Region
    12.1    North America
        12.1.1 United States
           12.1.1.1 Market Trends
           12.1.1.2 Market Forecast
        12.1.2 Canada
           12.1.2.1 Market Trends
           12.1.2.2 Market Forecast
    12.2    Asia Pacific
        12.2.1 China
           12.2.1.1 Market Trends
           12.2.1.2 Market Forecast
        12.2.2 Japan
           12.2.2.1 Market Trends
           12.2.2.2 Market Forecast
        12.2.3 India
           12.2.3.1 Market Trends
           12.2.3.2 Market Forecast
        12.2.4 South Korea
           12.2.4.1 Market Trends
           12.2.4.2 Market Forecast
        12.2.5 Australia
           12.2.5.1 Market Trends
           12.2.5.2 Market Forecast
        12.2.6 Indonesia
           12.2.6.1 Market Trends
           12.2.6.2 Market Forecast
        12.2.7 Others
           12.2.7.1 Market Trends
           12.2.7.2 Market Forecast
    12.3    Europe
        12.3.1 Germany
           12.3.1.1 Market Trends
           12.3.1.2 Market Forecast
        12.3.2 France
           12.3.2.1 Market Trends
           12.3.2.2 Market Forecast
        12.3.3 United Kingdom
           12.3.3.1 Market Trends
           12.3.3.2 Market Forecast
        12.3.4 Italy
           12.3.4.1 Market Trends
           12.3.4.2 Market Forecast
        12.3.5 Spain
           12.3.5.1 Market Trends
           12.3.5.2 Market Forecast
        12.3.6 Russia
           12.3.6.1 Market Trends
           12.3.6.2 Market Forecast
        12.3.7 Others
           12.3.7.1 Market Trends
           12.3.7.2 Market Forecast
    12.4    Latin America
        12.4.1 Brazil
           12.4.1.1 Market Trends
           12.4.1.2 Market Forecast
        12.4.2 Mexico
           12.4.2.1 Market Trends
           12.4.2.2 Market Forecast
        12.4.3 Others
           12.4.3.1 Market Trends
           12.4.3.2 Market Forecast
    12.5    Middle East and Africa
        12.5.1 Market Trends
        12.5.2 Market Breakup by Country
        12.5.3 Market Forecast
13    SWOT Analysis
    13.1    Overview
    13.2    Strengths
    13.3    Weaknesses
    13.4    Opportunities
    13.5    Threats
14    Value Chain Analysis
15    Porters Five Forces Analysis
    15.1    Overview
    15.2    Bargaining Power of Buyers
    15.3    Bargaining Power of Suppliers
    15.4    Degree of Competition
    15.5    Threat of New Entrants
    15.6    Threat of Substitutes
16    Competitive Landscape
    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players
        16.3.1    Agilent Technologies, Inc.
           16.3.1.1 Company Overview
           16.3.1.2 Product Portfolio 
           16.3.1.3 Financials
           16.3.1.4 SWOT Analysis 
        16.3.2    Berry Genetics, Inc.
           16.3.2.1 Company Overview
           16.3.2.2 Product Portfolio
        16.3.3    BGI Genomics Co., Ltd.
           16.3.3.1 Company Overview
           16.3.3.2 Product Portfolio 
           16.3.3.3 Financials
        16.3.4    Eurofins LifeCodexx GmbH
           16.3.4.1 Company Overview
           16.3.4.2 Product Portfolio 
           16.3.4.3 Financials
        16.3.5    F. Hoffmann-La Roche AG
           16.3.5.1 Company Overview
           16.3.5.2 Product Portfolio 
           16.3.5.3 SWOT Analysis 
        16.3.6    GE Healthcare
           16.3.6.1 Company Overview
           16.3.6.2 Product Portfolio
        16.3.7    Igenomix
           16.3.7.1 Company. Overview
           16.3.7.2 Product Portfolio 
           16.3.7.3 Financials
        16.3.8    Illumina, Inc.
           16.3.8.1 Company Overview
           16.3.8.2 Product Portfolio
           16.3.8.3 Financials
           16.3.8.4 SWOT Analysis 
        16.3.9    Laboratory Corporation
           16.3.9.1 Company Overview
           16.3.9.2 Product Portfolio 
           16.3.9.3 Financials 
           16.3.9.4 SWOT Analysis
        16.3.10    Natera, Inc.
           16.3.10.1 Company Overview
           16.3.10.2 Product Portfolio 
           16.3.10.3 Financials 
        16.3.11    Perkinelmer, Inc.
           16.3.11.1 Company Overview
           16.3.11.2 Product Portfolio 
           16.3.11.3 Financials 
           16.3.11.4 SWOT Analysis
        16.3.12    Thermo Fisher Scientific Inc.
           16.3.12.1 Company Overview
           16.3.12.2 Product Portfolio 
           16.3.12.3 Financials 
           16.3.12.4 SWOT Analysis
        16.3.13    Yourgene Health
           16.3.13.1 Company Overview
           16.3.13.2 Product Portfolio 
           16.3.13.3 Financials 
           
List of Figures

Figure 1: Global: Non-Invasive Prenatal Testing Market: Major Drivers and Challenges
Figure 2: Global: Non-Invasive Prenatal Testing Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Non-Invasive Prenatal Testing Market: Breakup by Product Type (in %), 2020
Figure 4: Global: Non-Invasive Prenatal Testing Market: Breakup by Test Type (in %), 2020
Figure 5: Global: Non-Invasive Prenatal Testing Market: Breakup by Technology (in %), 2020
Figure 6: Global: Non-Invasive Prenatal Testing Market: Breakup by Method (in %), 2020
Figure 7: Global: Non-Invasive Prenatal Testing Market: Breakup by Application (in %), 2020
Figure 8: Global: Non-Invasive Prenatal Testing Market: Breakup by End-User (in %), 2020
Figure 9: Global: Non-Invasive Prenatal Testing Market: Breakup by Region (in %), 2020
Figure 10: Global: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 11: Global: Non-Invasive Prenatal Testing (Consumables) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Non-Invasive Prenatal Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Non-Invasive Prenatal Testing (Instruments) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Non-Invasive Prenatal Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Non-Invasive Prenatal Testing (Materni 21) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Non-Invasive Prenatal Testing (Materni 21) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Non-Invasive Prenatal Testing (Harmony) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Non-Invasive Prenatal Testing (Harmony) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Non-Invasive Prenatal Testing (Panaroma) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Non-Invasive Prenatal Testing (Panaroma) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Non-Invasive Prenatal Testing (Verifi) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Non-Invasive Prenatal Testing (Verifi) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Non-Invasive Prenatal Testing (NIFTY) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Non-Invasive Prenatal Testing (NIFTY) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Non-Invasive Prenatal Testing (NGS) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Non-Invasive Prenatal Testing (NGS) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Non-Invasive Prenatal Testing (WGS) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Non-Invasive Prenatal Testing (WGS) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Global: Non-Invasive Prenatal Testing (Other Tests) Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Global: Non-Invasive Prenatal Testing (Other Tests) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Global: Non-Invasive Prenatal Testing (Trisomy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Global: Non-Invasive Prenatal Testing (Trisomy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Global: Non-Invasive Prenatal Testing (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Global: Non-Invasive Prenatal Testing (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: North America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: North America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: United States: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: United States: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Canada: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Canada: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Asia Pacific: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Asia Pacific: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: China: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: China: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Japan: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Japan: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: India: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: India: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: South Korea: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: South Korea: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Australia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Australia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Indonesia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Indonesia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Europe: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Europe: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Germany: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Germany: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: France: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: France: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: United Kingdom: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: United Kingdom: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Italy: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 86: Italy: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: Spain: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 88: Spain: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 89: Russia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 90: Russia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 91: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 92: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 93: Latin America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 94: Latin America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 95: Brazil: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 96: Brazil: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 97: Mexico: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 98: Mexico: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 99: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 100: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 101: Middle East and Africa: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 102: Middle East and Africa: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 103: Global: Non-Invasive Prenatal Testing Industry: SWOT Analysis
Figure 104: Global: Non-Invasive Prenatal Testing Industry: Value Chain Analysis
Figure 105: Global: Non-Invasive Prenatal Testing Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Non-Invasive Prenatal Testing Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
Table 3: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Test Type (in Million US$), 2021-2026
Table 4: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Technology Type (in Million US$), 2021-2026
Table 5: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Method (in Million US$), 2021-2026
Table 6: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 7: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup End-User (in Million US$), 2021-2026
Table 8: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 9: Global: Non-Invasive Prenatal Testing Market Structure
Table 10: Global: Non-Invasive Prenatal Testing Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Related Report

COVID-19 Sample Collection Kits Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Read More

Apoptosis Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Read More

Patient Engagement Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Read More

Medical Foods Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Read More

Proteinase K Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Read More

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Social Links